CSL Behring Sp. z o.o. secures contract for Pharmaceutical products - Delivery of drugs used in the treatment of MS treatment of patients with inflammation of the nose and paranasal sinuses with nasal polyps and immunoglobulins Drug programs

Poland, April 16 -- Poland based CSL Behring Sp. z o.o. has secured contract from Uniwersytecki Szpital Kliniczny w Olsztynie for Pharmaceutical products - Delivery of drugs used in the treatment of MS treatment of patients with inflammation of the nose and paranasal sinuses with nasal polyps and immunoglobulins Drug programs. The value of the contract is worth 20736320 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....